Liminal BioSciences Inc (LMNL)

NASDAQ
2.760
+0.150(+5.75%)
After Hours
2.710
-0.050(-1.812%)
- Real-time Data
  • Volume:
    232,803
  • Bid/Ask:
    2.650/2.710
  • Day's Range:
    2.560 - 2.830
  • Type:Equity
  • Market:United States
  • ISIN:CA53272L1031
  • CUSIP:00053272L103

LMNL Overview

Prev. Close
2.61
Day's Range
2.56-2.83
Revenue
1.51M
Open
2.61
52 wk Range
2.13-12.38
EPS
-2.88
Volume
232,803
Market Cap
88.63M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
912,062
P/E Ratio
-
Beta
1.73
1-Year Change
-78.08%
Shares Outstanding
29,943,839
Next Earnings Date
Nov 15, 2021
What is your sentiment on Liminal BioSciences Inc?
or
Market is currently closed. Voting is open during market hours.

Liminal BioSciences Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyNeutralStrong Sell
Technical IndicatorsSellSellStrong BuyStrong BuyStrong Sell
SummaryNeutralNeutralStrong BuyBuyStrong Sell

Liminal BioSciences Inc Company Profile

Liminal BioSciences Inc Company Profile

Employees
251

Liminal BioSciences Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing treatments for patients suffering from diseases primarily related to fibrosis, including respiratory, liver and kidney diseases. The Company operates through two segments: Small Molecule Therapeutics Segment and Plasma-derived Therapeutics Segment. The Small Molecule Therapeutics Segment is a small-molecule drug development business. Its lead small molecule product candidate is fezagepras (PBI-4050). The Plasma-derived Therapeutics Segment includes its plasma-derived therapeutics platform, which enables the development of its pipeline of biopharmaceutical candidates. Its lead plasma-derived product candidate is Ryplazim (plasminogen).

Read More
  • Time to buy
    1
    • 2.9
      0
      • This should be at $10 in a week
        0
        • It will hit 8 today
          2
          • or 4 :
            1
        • USD 6.3. sell now in after market
          0
          • Why not on monday? Maybe 7 or 8
            1
          • I think this is not go 7 dollar. ~6.3-6.5 and will be drop
            0
        • soon more high. Investors have seen that liminal at this price is GREAT especially than the overrated price of others biotech stock Price target 7$
          1
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.